Impact BioMedical Inc.
IBOAMEXHealthcare● Active
$0.56
$-0.01(-1.27%)
Market Cap$6996250
P/E Ratio—
52W High$1.95
52W Low$0.362
Impact BioMedical Inc.（IBO）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · IBO · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.03M | $1.62M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.42M | $0.00M | $0.00M | $1.11M | $1.11M |
| Gross Profit | ($0.39M) | $1.62M | $0.00M | ($1.11M) | ($1.11M) |
| Gross Margin %(computed) | — | 100.00% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.34M | $0.06M | $1.69M | $1.23M | $1.08M |
| G&A Expenses | $1.95M | $0.71M | $1.04M | $1.05M | $1.05M |
| Total Operating Expenses | $3.88M | $1.24M | $4.03M | $2.34M | $2.07M |
| Operating Income | ($4.27M) | $0.38M | ($4.03M) | ($3.45M) | ($3.19M) |
| Operating Margin %(computed) | — | 23.67% | — | — | — |
| Interest Income | $0.01M | $0.00M | $0.01M | $0.02M | $0.17M |
| Interest Expense | $0.79M | $0.12M | $0.44M | $0.46M | $0.30M |
| Income Before Tax | ($14.45M) | ($1.43M) | ($4.41M) | ($7.88M) | ($3.24M) |
| Income Tax Expense | ($2.58M) | $0.03M | $0.00M | ($0.62M) | ($1.40M) |
| Net Income | ($11.84M) | ($1.43M) | ($4.34M) | ($7.05M) | ($1.30M) |
| Net Margin %(computed) | — | -88.01% | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.38 | $-0.01 | $-0.07 | $-0.61 | $-0.61 |
| Wtd Avg Shares | 31.55M | 41.75M | 60.25M | 11.50M | 11.50M |
| EBITDA | ($12.51M) | ($1.07M) | ($2.84M) | ($2.34M) | ($2.07M) |
| EBITDA Margin %(computed) | — | -66.03% | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Impact BioMedical Inc.
关于Impact BioMedical Inc.（IBO）损益表
Impact BioMedical Inc.（IBO）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，IBO实现营收$0.00B，毛利润($0.00B)（毛利率-1225.00%），净利润($0.01B)（净利率-36993.75%）。
常见问题
IBO · 4 问Impact BioMedical Inc.（IBO）2025财年营收为$0.00B，同比down98.0%。
IBO revenueIBO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09